A study from SEMERGEN, Spain's primary care medical society, has found that elevated uric acid levels may signal heightened cardiovascular risk in women over 50 — a population whose heart health has long been measured by tools designed for other bodies. As estrogen fades and metabolic landscapes shift with menopause, this research suggests that a familiar compound, long associated with gout and kidney disease, may carry a quieter warning about the aging female heart. The finding invites clinicians to look more carefully at what routine blood work may already be telling them.
High Uric Acid Linked to Cardiovascular Risk in Women Over 50
Cobertura Relacionada
Mark Zuckerberg y su esposa compraron Strancally Castle, una propiedad neogótica de 1830 en Waterford, Irlanda, valorada…
Cadena SER · Aug 21 Las gafas inteligentes de Meta se prohíben en Reino Unido por preocupaciones de privacidadLas gafas inteligentes de Meta están siendo prohibidas en tribunales, pubs y teatros del Reino Unido por preocupaciones …
Infobae · Aug 21 GIGABYTE AORUS lanza en Argentina su notebook gamer más potente con Ryzen 9 y RTX 5090GIGABYTE AORUS presenta en Argentina la AORUS MASTER 16 (Gen 2), una notebook gamer de gama alta equipada con procesador…
EL UNIVERSAL · Aug 21 Apple Maps despliega caminantes con cámaras 360° para cartografiar zonas inaccesiblesApple financia a personas equipadas con cámaras de 360 grados y GPS para cartografiar áreas inaccesibles a vehículos, me…
Sesgo y Encuadre
Article content is inaccessible; only cookie policy text provided. Unable to assess bias in the actual health research reporting.
Impacto Geopolítico
Medical research article on cardiovascular health markers in women; no geopolitical significance.
Lente Económico
Medical research linking elevated uric acid to cardiovascular risk in women over 50 has limited direct economic impact but signals potential growth in diagnostic testing and preventive healthcare markets.
Consumers may face increased healthcare costs through expanded screening programs for uric acid levels and potential preventive treatments. Women over 50 may experience higher insurance premiums or copays for cardiovascular risk assessments and management.
Health authorities may recommend updated screening guidelines for women over 50, potentially increasing public health spending. Insurance companies may adjust coverage policies for uric acid testing and preventive cardiology services. Pharmaceutical companies may pursue development of uric acid-lowering therapies.